BSESangam Health Care Products LtdMinimalNeutral
Announced Thu, 9 Jul · 16:39 IST
Routine compliance certificate for Q1 FY27 dematerialization
Compliance View source PDF
Price reaction · full curve
Awaiting price reaction for this filing.
AI summary
Sangam Health Care Products filed a routine compliance certificate under SEBI Regulation 74(5) for the quarter ended 30 June 2026. The Registrar and Transfer Agent XL Softech Systems confirmed that all securities received for dematerialization were mutilated, cancelled, and the depository name was substituted as registered owner within the required 30 days. This is a standard procedural filing with no business or financial impact.
Likely market impact
Routine regulatory filing. No impact on business, financials, or shareholders.